Roche is deeply committed to supporting the Canadian response to put an end to the COVID-19 pandemic. In Canada, our team is working with urgency, passion and purpose each and every day to deliver high-quality tests that are essential for our healthcare systems across the country and patients alike.

Reliable, high-quality tests to deliver effective results

As a leader in diagnostics testing, we have a responsibility to deliver effective solutions for patients fast. Testing is a critical part in fighting this unprecedented healthcare emergency, and we are proud to be able to contribute.

After having launched a PCR test to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, we have been diligently and urgently working to bring a reliable immunoassay solution to the market.

Roche Diagnostics COVID-19 Testing Journey in Canada


The Elecsys qualitative anti-SARS CoV-2 test is not recommended for the assessment of post-vaccination serological status with vaccines currently available in Canada*

* As of February 2021


An overview of SARS-CoV-2 diagnostic tests currently available in Canada
For more information on Roche Group SARS-CoV-2 products and solutions, visit the Global website at


table covid

Why antibody tests are so important

When to use which SARS-Cov-2 diagnostic test?


For more information on Roche SARS-CoV-2 products and solutions, visit


COVID-19: coronavirus disease 2019
RT-PCR: reverse transcription polymerase chain reaction

1. European Commission (2020). Guidelines on COVID-19 in vitro diagnostic tests and their performance (published 15 April 2020). Available from [Accessed April 2020].